Screening for Hepatocellular Carcinoma in Patients With Cirrhosis in The United States: Results of A National Survey

Abstract

The majority of respondents routinely screen patients with cirrhosis for HCC. Approximately half of the screening respondents limit their screening to only patients with high-risk etiologies. On multivariate analysis, several variables predicted screening for HCC by the respondents.